Recurrent SF3B1 mutations have been reported in various cancer types, including chronic lymphocytic leukemia (CLL), and shown to induce altered splicing by alternative branch point usage or cryptic 3′ splice site selection [2–4]. The gene discussed is SF3B1; the disease is cancer.